BioApplications Email Formats
Biotechnology Research • 
394, Jigok-ro, Korea, Republic of • 1-10 Employees
Key Contact at BioApplications
Bo-Hwa Choi 한줄프로필
Marketing Director
Company overview
| Headquarters | 394, Jigok-ro, Korea, Republic of |
| Website | |
| NAICS | 541714 |
| Keywords | Animal Vaccines And Alternative Meat Proteins |
| Founded | 2011 |
| Employees | 1-10 |
About BioApplications
BioApp was established in 2011 based on POSTECH's plant biotechnology. It has achieved significant milestones, being the first to accomplish various achievements in both Korea and globally. Notably, the HERBAVAC™ CSF Green Marker vaccine, the world's inaugural plant-based classical swine fever vaccine, has been approved. BioApp aims to contribute to eliminating classical swine fever by achieving CSF-free status in Korea and entering the global market. Beyond animal vaccines, BioApp is engaged in developing vaccines for COVID-19, Zika, and dementia prevention. The company strives to establish a green vaccine production system to ensure swift delivery of secure and efficient vaccines, enhancing vaccine self-sufficiency to safeguard public health from severe infectious diseases.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
BioApplications has never raised funding before.
BioApplications Tech Stack
Discover the technologies and tools that power BioApplications's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
JavaScript libraries
Miscellaneous
Security
Miscellaneous
Translation
Page builders
JavaScript libraries
Maps
Font scripts
United States
United Kingdom
France
Frequently asked questions
4.8
40,000 users
